  |
 | Up a level |
Pivot, Xavier B and Bondarenko, Igor and Dvorkin, Mikhail and Trishkina, Ekaterina and Ahn, Jin-Hee and Im, Seock-Ah and Sarosiek, Tomasz and Chattopadhyay, Sanjay and Wojtukiewicz, Marek and Moiseyenko, Vladimir and Shparyk, Yaroslav V and Bello, Maximino De Guzman and Semiglazov, Vladimir and Song, Sujeong and Lim, Jae Yun (2017) A randomized, double-blind, phase III study comparing SB3 (trastuzumab biosimilar) with originator trastuzumab in patients treated by neoadjuvant therapy for HER2-positive early breast cancer. Journal of Clinical Oncology, 35 (15). p. 509. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Aapro, Matti and Karthaus, Meinolf and Schwartzberg, Lee and Bondarenko, Igor and Sarosiek, Tomasz and Oprean, Cristina and Cardona-Huerta, Servando and Hansen, Vincent and Rossi, Giorgia and Rizzi, Giada and Borroni, Maria Elisa and Rugo, Hope (2017) NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron. Supportive Care in Cancer, 25 (4). pp. 1127-1135. ISSN 0941-4355 (Print) 1433-7339 (Online)
